Clinical Trial Update: Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial investigating infliximab with pegylated interferon and ribavirin for hepatitis C has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Infliximab (infliximab)
• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Nizar Zein | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2017-09-13